...Rouhandeh will step down as executive chairman while retaining a board seat. Monopar closes IPO Monopar Therapeutics Inc....
...see “Syncona’s Sister Act” ). Elizabeth S. Eaton, Staff Writer Qiagen N.V. Abeona Therapeutics Inc. Cirius Therapeutics Inc. Axsome Therapeutics Inc. Monopar Therapeutics Inc. Paige.AI...

...Bio-Medical Technology Co. Ltd. (Shanghai) 8/27/19 $50.3 Mkt (generic) TFF Pharmaceuticals Inc. 8/20/19 $22.0 Preclin Monopar Therapeutics Inc....

...propose IPOs SpringWorks Therapeutics Inc. (Stamford, Conn.), Satsuma Pharmaceuticals Inc. (South San Francisco, Calif.) and Monopar Therapeutics Inc....
...up to 99%. Val Kennedy, Associate Editor and Elizabeth S. Eaton, Staff Writer Bellicum Pharmaceuticals Inc. Generex Biotechnology Corp. Monopar Therapeutics Inc. Satsuma...

...Cancer company Monopar Therapeutics Inc. (Northbrook, Ill.) said it acquired candidates including GPX-150 from Gem Pharmaceuticals LLC (Pelham...
...to the filing. Monopar Therapeutics Inc., Northbrook, Ill. Gem Pharmaceuticals LLC, Pelham, Ala. Business: Cancer Allison Johnson GPX-150 Gem Pharmaceuticals LLC Monopar Therapeutics Inc....

...Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO) granted Monopar Therapeutics Inc. (Northbrook, Ill.) exclusive, worldwide rights to Validive clonidine lauriad (BA-028...
...Phase III study. Onxeo S.A. (Euronext:ONXEO; CSE:ONXEO), Paris, France Monopar Therapeutics Inc., Northbrook, Ill. Business: Other Chris Lieu Clonidine Lauriad Validive Monopar Therapeutics...

...urokinase receptor ( PLAUR ; uPAR ; suPAR ). Cancer Research UK , London, U.K. Monopar Therapeutics...